Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| IMNN | IMUNON INC | $12.61M | 2,192,353 | 19.70% | 80.30% | Net Buying | Net Buying | ||
| ACXP | ACURX PHARMACEUTICALS INC | $6.83M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| FBLG | FIBROBIOLOGICS INC | $22.75M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $35.63M | 4,990,692 | 30.75% | 69.25% | Net Selling | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $68.35M | 17,661,698 | 29.13% | 25.91% | ||||
| FEMY | FEMASYS INC | $10.68M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| PSTV | PLUS THERAPEUTICS INC | $44.67M | 99,264,526 | 0.38% | 23.66% | Net Buying | Net Buying | ||
| REE | REE AUTOMOTIVE LTD | $16.16M | 22,259,447 | 24.81% | 45.27% | ||||
| CODX | CO-DIAGNOSTICS INC | $13.14M | 38,523,582 | 13.37% | 25.74% | Net Selling | |||
| CBUS | CIBUS INC | $73.76M | 54,238,382 | 21.28% | 78.72% | Net Buying | |||
| CLSD | CLEARSIDE BIOMEDICAL INC | $24.87M | 77,708,536 | 12.08% | 35.27% | Net Buying | |||
| MBRX | MOLECULIN BIOTECH INC | $11.02M | 30,286,168 | 1.43% | 20.90% | Net Buying | Net Buying | ||
| SGMO | SANGAMO THERAPEUTICS INC | $152.36M | 301,709,485 | 16.98% | 10.66% | Net Selling | Net Selling | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $28.77M | 57,542,105 | 11.22% | 38.43% | Net Selling | |||
| MTVA | METAVIA INC | $16.84M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| FGEN | FIBROGEN INC | $48.65M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Buying | ||
| GRI | GRI BIO INC | $4.55M | 2,515,305 | 0.71% | 99.29% | ||||
| GOVX | GEOVAX LABS INC | $17.80M | 25,359,593 | 0.21% | 99.79% | Net Buying | Net Buying | ||
| NRXP | NRX PHARMACEUTICALS INC | $55.17M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| LSTA | LISATA THERAPEUTICS INC | $18.83M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| IMUX | IMMUNIC INC | $76.08M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| XFOR | X4 PHARMACEUTICALS INC | $18.87M | 5,788,686 | 26.19% | 73.81% | Net Selling | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.79M | 51,806,497 | 16.36% | 46.67% | Net Buying | |||
| JSPR | JASPER THERAPEUTICS INC | $39.50M | 16,253,332 | 20.02% | 79.98% | Net Buying | |||
| MDCX | MEDICUS PHARMA LTD | $42.94M | 17,816,266 | 11.72% | 55.54% | Net Buying | Net Buying | ||
| INTS | INTENSITY THERAPEUTICS INC | $10.92M | 47,057,727 | 4.20% | 4.44% | Net Buying | Net Buying | ||
| MYO | MYOMO INC | $31.90M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.94M | 1,919,441 | 4.26% | 95.74% | Net Buying | |||
| ACRV | ACRIVON THERAPEUTICS INC | $47.81M | 31,455,645 | 54.52% | 45.48% | Net Selling | Net Selling | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.53M | 23,858,301 | 10.74% | 60.23% | ||||
| CING | CINGULATE INC | $21.38M | 5,412,523 | 3.75% | 96.25% | ||||
| EKSO | EKSO BIONICS HOLDINGS INC | $10.00M | 2,611,788 | 0.26% | 99.74% | ||||
| CRIS | CURIS INC | $22.75M | 12,498,853 | 6.98% | 93.02% | ||||
| OSTX | OS THERAPIES INC | $71.76M | 31,891,933 | 1.89% | 20.70% | Net Selling | |||
| CYBN | CYBIN INC | $140.27M | 23,033,127 | 36.01% | 0.00% | ||||
| BTAI | BIOXCEL THERAPEUTICS INC | $45.27M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| PASG | PASSAGE BIO INC | $22.25M | 3,178,710 | 48.59% | 51.41% | Net Selling | Net Selling | ||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | 82,674,725 | 7.82% | 0.00% | ||||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.51M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| LGVN | LONGEVERON INC | $11.96M | 15,178,575 | 3.85% | 96.15% | Net Selling | Net Selling | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.33M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| AMTX | AEMETIS INC | $136.60M | 63,240,956 | 8.08% | 91.92% | Net Buying | Net Selling | ||
| SLN | SILENCE THERAPEUTICS PLC | $212.81M | 141,701,848 | 13.95% | 0.09% | ||||
| IPSC | CENTURY THERAPEUTICS INC | $43.28M | 86,389,098 | 26.19% | 47.24% | Net Selling | Net Selling | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $250.73M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| CABA | CABALETTA BIO INC | $93.37M | 50,743,101 | 94.52% | 5.48% | ||||
| ATOS | ATOSSA THERAPEUTICS INC | $108.50M | 129,171,424 | 16.53% | 11.04% | Net Buying | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $62.29M | 24,425,762 | 54.13% | 45.87% | Net Selling | Net Selling | ||
| NKTX | NKARTA INC | $139.92M | 71,024,512 | 62.30% | 37.70% | Net Selling | Net Selling | ||
| ACET | ADICET BIO INC | $66.99M | 82,709,625 | 62.39% | 19.44% | Net Selling | |||
| CNTX | CONTEXT THERAPEUTICS INC | $74.90M | 89,704,194 | 76.50% | 1.46% | Net Buying | |||
| HUMA | HUMACYTE INC | $232.81M | 158,372,173 | 35.97% | 19.03% | Net Selling | Net Selling | ||
| OCGN | OCUGEN INC | $312.77M | 292,304,736 | 17.67% | 10.44% | Net Selling | |||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $63.37M | 20,984,161 | 30.21% | 69.79% | Net Buying | |||
| FBRX | FORTE BIOSCIENCES INC | $131.29M | 12,432,854 | 61.45% | 38.55% | Net Buying | Net Selling | ||
| NOTE | FISCALNOTE HOLDINGS INC | $65.58M | 14,349,995 | 30.70% | 69.30% | Net Selling | Net Selling | ||
| SNTI | SENTI BIOSCIENCES INC | $35.21M | 26,081,139 | 20.78% | 79.22% | Net Buying | |||
| ABOS | ACUMEN PHARMACEUTICALS INC | $79.96M | 60,573,425 | 62.08% | 17.23% | Net Selling | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $367.28M | 266,141,411 | 62.35% | 0.00% | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $30.06M | 68,003,613 | 21.00% | 15.70% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.